Cerus Corp.
(NASDAQ : CERS)

( )
CERS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.85%562.901.0%$969.77m
DHRDanaher Corp. -1.63%266.790.7%$851.33m
ABTAbbott Laboratories -2.60%120.070.8%$788.13m
MDTMedtronic Plc -0.12%104.050.6%$679.30m
ISRGIntuitive Surgical, Inc. 0.12%264.460.8%$562.41m
ALGNAlign Technology, Inc. -2.27%457.366.4%$388.51m
DXCMDexCom, Inc. -2.56%395.837.8%$351.55m
BSXBoston Scientific Corp. 1.25%43.041.0%$350.41m
SYKStryker Corp. -0.37%248.351.3%$340.27m
BDXBecton, Dickinson & Co. -1.67%253.801.0%$320.96m
EWEdwards Lifesciences Corp. -0.78%108.640.4%$243.40m
AAgilent Technologies, Inc. -0.89%133.371.6%$233.69m
IDXXIDEXX Laboratories, Inc. -2.44%466.523.8%$224.09m
ZBHZimmer Biomet Holdings, Inc. -0.39%120.481.7%$211.00m
BAXBaxter International, Inc. -0.96%84.251.8%$189.09m

Company Profile

Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.